Authors:
Peiro, G
Diebold, J
Mayr, D
Baretton, GB
Kimmig, R
Schmidt, M
Lohrs, U
Citation: G. Peiro et al., Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma, MOD PATHOL, 14(8), 2001, pp. 777-783
Authors:
Weisenburger, DD
Anderson, JR
Diebold, J
Gascoyne, RD
MacLennan, KA
Muller-Hermelink, HK
Nathwani, BN
Ullrich, F
Armitage, JO
Citation: Dd. Weisenburger et al., Systemic anaplastic large-cell lymphoma: Results from the non-Hodgkin's lymphoma classification project, AM J HEMAT, 67(3), 2001, pp. 172-178
Authors:
Peiro, G
Diebold, J
Baretton, GB
Kimmig, R
Lohrs, U
Citation: G. Peiro et al., Cellular apoptosis susceptibility gene expression in endometrial carcinoma: Correlation with Bcl-2, Bax, and caspase-3 expression and outcome, INT J GYN P, 20(4), 2001, pp. 359-367
Authors:
Jourdan, F
Molina, T
Rigau, V
Le Tourneau, A
Diebold, J
Marie, JP
Audouin, J
Citation: F. Jourdan et al., Cutaneous manifestations of B-CLL masked by florid epithelioid granulomatous response, ANN PATHOL, 21(4), 2001, pp. 340-343
Authors:
Audouin, J
Le Tourneau, A
Molina, T
Camilleri-Brolt, S
Diebold, J
Citation: J. Audouin et al., Histopathologic diagnosis of malignant lymphomas based on classification of World Health Organization, EXP ONCOL, 23(2), 2001, pp. 136-138
Authors:
Cazals-Hatem, D
Andre, M
Mounier, N
Copin, MC
Divine, M
Berger, F
Bosly, A
Kerneis, Y
Briere, J
Quesnel, B
Diebold, J
Gaulard, P
Citation: D. Cazals-hatem et al., Pathologic and clinical features of 77 Hodgkin's lymphoma patients treatedin a lymphoma protocol (LNH87) - A GELA study, AM J SURG P, 25(3), 2001, pp. 297-306
Authors:
Chanel, S
Burke, L
Fiche, M
Molina, T
Lerochais, JP
Icard, P
Diebold, J
Galateau-Salle, F
Citation: S. Chanel et al., Synchronous pulmonary adenocarcinoma and extranodal marginal zone/low-grade B-cell lymphoma of malt type, HUMAN PATH, 32(1), 2001, pp. 129-132
Authors:
Molina, TJ
Delmer, A
Cymbalista, F
Le Tourneau, A
Perrot, JY
Ramond, S
Marie, JP
Audouin, J
Zittoun, R
Diebold, J
Citation: Tj. Molina et al., Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome, VIRCHOWS AR, 437(6), 2000, pp. 591-598
Authors:
Harris, NL
Jaffe, ES
Diebold, J
Flandrin, G
Muller-Hermelink, HK
Vardiman, J
Citation: Nl. Harris et al., Lymphoma classification - from controversy to consensus: The REAL and WHO Classification of lymphoid neoplasms, ANN ONCOL, 11, 2000, pp. 3-10
Authors:
Harris, NL
Jaffe, ES
Diebold, J
Flandrin, G
Muller-Hermelink, HK
Vardiman, J
Lister, TA
Bloomfield, CD
Citation: Nl. Harris et al., The World Health Organization classification of hematological malignanciesreport of the Clinical Advisory Committee Meeting, Airlie House, Virginia,November 1997, MOD PATHOL, 13(2), 2000, pp. 193-207
Authors:
Mayr, D
Pannekamp, U
Baretton, GB
Gropp, M
Meier, W
Flens, MJ
Scheper, R
Diebold, J
Citation: D. Mayr et al., Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas, PATH RES PR, 196(7), 2000, pp. 469-475
Authors:
Dufau, JP
Le Tourneau, A
Molina, T
Le Houcq, M
Claessens, YE
Rio, B
Delmer, A
Diebold, J
Citation: Jp. Dufau et al., Intravascular large B-cell lymphoma with bone marrow involvement at presentation and haemophagocytic syndrome: two Western cases in favour of a specific variant, HISTOPATHOL, 37(6), 2000, pp. 509-512
Authors:
Diebold, J
Molina, T
Camilleri-Broet, S
le Tourneau, A
Audouin, J
Citation: J. Diebold et al., Bone marrow manifestations of infections and systemic diseases observed inbone marrow trephine biopsy, HISTOPATHOL, 37(3), 2000, pp. 199-211
Authors:
Kaltz-Wittmer, C
Klenk, U
Glaessgen, A
Aust, DE
Diebold, J
Lohrs, U
Baretton, GB
Citation: C. Kaltz-wittmer et al., FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy, LAB INV, 80(9), 2000, pp. 1455-1464
Authors:
Huss, R
Weissinger, EM
Lange, C
Gatsios, P
Eissner, G
Kolb, HJ
Diebold, J
Heinrich, PC
Graeve, L
Citation: R. Huss et al., In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62(dok) protein, J PATHOLOGY, 192(3), 2000, pp. 363-372
Authors:
Diebold, J
Mosinger, K
Peiro, G
Pannekamp, U
Kaltz, C
Baretton, GB
Meier, W
Lohrs, U
Citation: J. Diebold et al., 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization, J PATHOLOGY, 190(5), 2000, pp. 564-571
Authors:
Hillemanns, P
Untch, M
Dannecker, C
Baumgartner, R
Stepp, H
Diebold, J
Weingandt, H
Prove, F
Korell, M
Citation: P. Hillemanns et al., Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid, INT J CANC, 85(5), 2000, pp. 649-653
Authors:
Hein, J
Kempf, VAJ
Diebold, J
Bucheler, N
Preger, S
Horak, I
Sing, A
Kramer, U
Autenrieth, IB
Citation: J. Hein et al., Interferon consensus sequence binding protein confers resistance against Yersinia enterocolitica, INFEC IMMUN, 68(3), 2000, pp. 1408-1417
Authors:
Thaler, CJ
Sepp, A
Brake, I
Diebold, J
Heyn, R
Citation: Cj. Thaler et al., Predictive value of endometrial cells in cervical smears reflecting endometrial pathology: Effects of hormonal replacement therapy, GEBURTSH FR, 60(10), 2000, pp. 508-512